Simoa® Accelerator Laboratory
Protein biomarker testing and custom
assay development services
Empowering researchers to bring new discoveries in disease and treatment to the forefront with our Simoa precision instruments, wide-ranging menu of assay kits, and custom assay development services.
EXPLORE OUR SERVICESSimoa Technology:
Measure biomarkers at lower
levels than ever before.
Our digital health solution, Simoa, enables development of methods providing much earlier disease detection, better prognoses and enhanced treatment methods to improve the quality of life and longevity of the population for generations to come.
Simoa is changing the way in which the biology of health and disease is studied by giving researchers the ability to closely examine critical biomarkers in a majority of therapeutic areas, including neurology, infectious disease, oncology, inflammation, and cardiology.
Discover Simoa Technology
Learn More About the Science Behind Simoa®
LEARN ABOUT OUR THERAPEUTIC AREAS
Precision science applied to the biology of health & disease
We’re committed to catalyzing the science first, with several hundred peer-reviewed science journal publications showcasing the impact the Simoa technology is making in the fields of oncology, neurology, cardiology, inflammation and infectious disease.
Over 170 Peer-reviewed oncology publications using Simoa® Technology
Single-plex and multiplex assays available to measure relevant oncology biomarkers in multiple sample types
Ultrasensitive bead and planar array platforms allow quantification of key targets at baseline and disease levels
Assay kits measure up to 4 neurological targets simultaneously in blood or CSF
Over 500 peer-reviewed publications featuring Simoa® technology
Neurolgy research supported by Simoa® bead technology
Simoa® biomarker assays to facilitate the research on Alzheimer’s disease, Parkinson’s disease, Multiple Sclerosis, TBI, and more
Commercially-available assay kits measure 17 individual cardiology targets in multiple sample types with precision and sensitivity
Use of ultrasensitive Simoa® bead and planar array platforms in cardiology studies supported by peer-reviewed research
Area of study supported by both Simoa® bead and planar array technologies
Ultrasensitive Simoa® bead and planar platforms facilitated over 150 peer-reviewed research publications
Assay kits measure key markers of inflammation in singleplex and multiplex configurations
Ultrasensitive bead and planar array platforms allow quantification of key targets at baseline and disease levels
Over 100 peer-reviewed research articles in infectious diseases using Simoa®
Simoa® bead and planar technologies enable research on a range of infectious diseases, including HIV and COVID-19
Ultrasensitive singleplex and multiplex assays measure essential markers of disease activity and severity
Ultrasensitive bead and planar array platforms allow quantification of key targets at baseline and disease levels